Sinco Pharmaceuticals: (1) SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ACQUISITION OF OPCO AND THE EQUITY TRANSFER AGREEMENTS; (2) COMPLETION OF THE EQUITY TRANSFER AGREEMENTS; AND (3) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE ENTERING INTO THE

May 11, 2022 06:07

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

興科蓉醫藥：(1)有關收購OPCO及股權轉讓協議的補充公告； (2)完成股權轉讓協議；及 (3)有關訂立VIE合約安排的持續關連交易

Sinco Pharmaceuticals: (1) SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ACQUISITION OF OPCO AND THE EQUITY TRANSFER AGREEMENTS; (2) COMPLETION OF THE EQUITY TRANSFER AGREEMENTS; AND (3) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE ENTERING INTO THE

Risk Disclaimer

Statement